Evaluation of insulin sensitivity with a new lipid-based index in non-diabetic postmenopausal overweight and obese women before and after a weight loss intervention

European Journal of Endocrinology

Volumn 161, Issue 1, 2009, Pages 51-56

  Antuna Puente, Barbara ^a,b   Disse, Emmanuel ^c   Faraj, May ^d,e   Lavoie, Marie Eve ^d   Laville, Martine ^c   Rabasa Lhoret, Rémi ^d,e,f   Bastard, Jean Philippe ^a,b,g  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISSE INDEX; ENDOCRINE PANCREAS FUNCTION TEST; FEMALE; GLUCOSE CLAMP TECHNIQUE; HIGH RISK POPULATION; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSTRUMENT VALIDATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MCAULEY INDEX; MENOPAUSE RELATED DISORDER; OBESITY; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RELIABILITY; VALIDATION PROCESS; WEIGHT REDUCTION; WOMEN'S HEALTH; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS; DIET THERAPY; ENDOCRINE SYSTEM EXAMINATION; HOMEOSTASIS; LIPOLYSIS; LOW CALORY DIET; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POSTMENOPAUSE; REPRODUCIBILITY; STANDARD; VALIDATION STUDY;

FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CHOLESTEROL, HDL; DIABETES MELLITUS; DIAGNOSTIC TECHNIQUES, ENDOCRINE; DIET, REDUCING; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPOLYSIS; MIDDLE AGED; OBESITY; OVERWEIGHT; POSTMENOPAUSE; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 67650730855     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0091     Document Type: Article

References (31)

1. DeFronzo RA. Lilly lecture 1987: the triumvirate: beta-cell, muscle, liver. Collusion responsible for NIDDM. Diabetes 1988 37 667-687.
2. DeFronzo RA, Tobin JD & Andreas R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 1979 85 E214-E223.
3. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410.
4. McAuley K, Williams S, Mann J, Walker R, Lewis-Barned N, Temple L & Duncan A. Diagnosing insulin resistance in the general population. Diabetes Care 2001 24 460-464.
5. Perseghin G, Caumo A, Caloni M, Testolin G & Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in non-obese individuals. Journal of Clinical Endocrinology and Metabolism 2001 86 4776-4781.
6. Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F, Bruezau J, Louche-Pellissier C, Mitrepierre C, Peyrat J, Chagne J, Vidal H & Laville M. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. Journal of Clinical Endocrinology and Metabolism 2003 88 4917-4923.
7. Disse E, Bastard JP, Bonnet F, Maitrepierre C, Peyrat J, Louche-Pelisser C & Laville M. A lipid-parameter-based index for estimating insulin sensitivity and identifying insulin resistance in healthy populations. Diabetes and Metabolism 2008 34 457-463.
8. Piché M-E, Weisnagel J, Corneau L, Nadeau A, Bergeron J & Lemieux S. Contribution of abdominal viceral obesity and insulin resistance to cardiovascular risk profile of postmenopausal women. Diabetes 2005 54 770-777.
9. You T, Ryan A & Nicklas B. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat and inflammation. Journal of Clinical Endocrinology and Metabolism 2004 89 5517-5522.
10. Bastard JP, Vandernotte JM, Faraj M, Karelis AD, Messier L, Garrel D, Prud'homme D & Rabasa-Lhoret R. Relationship between the hyperinsulinemic-euglycemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women. Diabetes and Metabolism 2007 33 261-268.
11. Karelis AD, Faraj M, Bastard JP, St-Pierre D, Brochu M, Prud'homme D & Rabasa-Lhoret R. The metabolically healthy, but obese individual presents a favorable inflammation profile. Journal of Clinical Endocrinology and Metabolism 2005 90 4145-4150.
12. Faraj M, Messier L, Bastard JP, Tardif A, Godbout A, Prud'homme D & Rabasa-Lhoret R. Apoprotein B: a predictor of inflammatory status in post-menopausal overweight and obese women. Diabetologia 2006 49 1637-1646.
13. Diamanti-Kandarakis E, Kouli C, Alexandraki K & Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 1273-1276.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
15. Dawson B & Trapp RG. Comparing correlations with variables in common in the same group coefficients. In Basic & Clinical Biostatistics, edn 4, ch 8, pp 196-198. USA: Lange Medical Books/ McGraw-Hill Companies Inc., 2004.
16. Abdul-Ghani MA, Matsuda M, Balas B & DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 2007 30 89-94.
17. Ferranini E & Mari A. How to measure insulin sensitivity. Journal of Hypertension 1998 16 895-906.
18. Muniyappa R, Lee S, Chen H & Quon M. Current approaches for insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiology. Endocrinology and Metabolism 2008 294 E15-E26.
19. Katzuki A, Sumida Y, Gabazza E, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y & Adachi Y. QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2002 87 2906-2908.
20. Bastard JP, Jan V, Maachi M, Rabasa-Lhoret R, Jardel C, Bruckert E, Laville M & Hainque B. Incorporation of nonesterified fatty acids into QUICKI is not relevant in obese subjects during diet inducing weight loss. Diabetes and Metabolism 2002 28 333-334.
21. Brunani A, Caumo A, Graci S, Margarini C, Viberti GC & Liuzzi A. Revised vs original QUICKI index during diet C rosiglitazone treatment in obese subjects. Diabetes and Metabolism 2004 30 409-410.
22. Vaccaro O, Masulli M, Cuomo V, Albarosa Riveliese A, Uusitupa M, Vessby B, Hermansen K, Tapsell L & Riccardi G. Comparative evaluation of simple indices of insulin resistance. Metabolism 2004 53 1522-1526.
23. Ijzerman RG, Stehouwer CD, Serné EH, Voordouw JJ, Smulders YM, Delemarre-van de Waal HA & van Weissenbruch MM. Incorporation of the fasting free fatty acid concentration into quantitative insulin sensitivity check index improves its association with insulin sensitivity in adults, but not in children. European Journal of Endocrinology 2009 160 59-64.
24. Abbasi F, McLauglhin T, Lamendola C & Reaven GM. The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose free fatty acid concentrations in healthy volunteers. Journal of Clinical Endocrinology and Metabolism 2000 85 1251-1254.
25. Krebs M, Stingl H, Nowotny P, Weghuber D, Bischof M, Waldhäusl W & Roden M. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clinical Chemistry 2000 46 950-954.
26. Kim SH, Abbasi F & Reaven GM. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 2004 27 1998-2002.
27. Ruige JB, Mertens IL, Bartholomeeusen E, Dirinck E, Ferrannini E & Van Gaal LF. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal. Obesity 2006 14 1250-1256.
28. Coon P, Rogus E, Drinkwater D, Muller D & Goldberg A. Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. Journal of Clinical Endocrinology and Metabolism 1992 75 1125-1132.
29. Ozbey N, Sencer E, Molvalilar S & Orhan Y. Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocrine Journal 2002 49 503-509.
30. Lapointe A, Piché M-E, Weisnagel S, Bergeron J & Lemieux S. Associations between circulating free fatty acids, visceral adipose tissue accumulation, and insulin sensitivity in postmenopausal women. Metabolism 2009 58 180-185.
31. Brochu M, Mathieu M-E, Karelis A, Doucet E, Lavoie M-E, Garrel D & Rabasa-Lhoret R. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet Study. Obesity 2008 16 1085-1093.